HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy.

Abstract
Normal human erythrocyte phosphofructokinase (ATP: D-fructose-6, P-1-phosphotransferase, EC 2.7.1.11; PFK) has recently been shown to consist of a heterogeneous mixture of five tetrameric isozymes: M4, M3L, M2L2, ML3, and L4 (M, muscle type; L, liver type). In the light of these findings, we have investigated the molecular basis of the inherited erythrocyte PFK deficiency associated with myopathy and hemolysis (Tarui disease). The propositus, a 31-yr-old male, suffered from muscle weakness and myoglobinuria on exertion. He showed mild erythrocytosis despite laboratory evidence of hemolysis. In his erythrocytes a metabolic crossover point was found at the level of PFK; 2,3-diphosphoglycerate (2,3-DPG) was also significantly reduced. The PFK from the patient's erythrocytes consisted exclusively of the L4 isozyme, and there was a complete absence of the other four. The leukocyte and platelet PFKs from the patient showed normal activities, chromatographic profiles, and precipitation with anti-M4 antibody. These studies provide direct evidence that in Tarui disease the M-type subunits are absent; but the liver- and platelet-type subunits of PFK are unaffected. The paradox of mild erythrocytosis despite hemolysis reflects the decreased production of 2,3-DPG.
AuthorsS Vora, L Corash, W K Engel, S Durham, C Seaman, S Piomelli
JournalBlood (Blood) Vol. 55 Issue 4 Pg. 629-35 (Apr 1980) ISSN: 0006-4971 [Print] United States
PMID6444532 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Diphosphoglyceric Acids
  • Isoenzymes
  • Phosphofructokinase-1
Topics
  • Adult
  • Blood Platelets (enzymology)
  • Diphosphoglyceric Acids (deficiency)
  • Erythrocytes (enzymology)
  • Hemolysis
  • Humans
  • Isoenzymes (analysis)
  • Leukocytes (enzymology)
  • Liver (enzymology)
  • Male
  • Muscle Hypotonia (genetics)
  • Myoglobinuria (genetics)
  • Phosphofructokinase-1 (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: